3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Colonoscopy
67
Blood Specimen Collection
64
Standard of Care
60
Exercise
59
Radiosurgery
53
Drug Therapy
49
Radiofrequency Ablation
47
Endoscopic Mucosal Resection
47
Radiotherapy
45
Surgical Procedures, Operative
44
Methods
43
Early Intervention, Educational
40
Surveys and Questionnaires
39
Oxaliplatin
38
Laparoscopy
34
Educational Status
34
Fluorouracil
33
Magnetic Resonance Spectroscopy
28
Gemcitabine
26
Biopsy
26
Preoperative Exercise
25
Practice Guidelines as Topic
24
Control Groups
24
lenvatinib
23
Patient Navigation
23
Electroporation
23
Capecitabine
22
camrelizumab
20
Saline Solution
20
Liver Transplantation
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Gastrointestinal
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled